Hepatitis C Virus Core Protein Upregulates Transforming Growth Factor-β1 Transcription

Journal of Medical Virology

Volumn 72, Issue 1, 2004, Pages 52-59

  Taniguchi, Hiroyoshi ^a   Kato, Naoya ^a   Otsuka, Motoyuki ^a   Goto, Tadashi ^a   Yoshida, Hideo ^a   Shiratori, Yasushi ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Liver fibrosis; MAPK pathway; Nucleocapsid

Indexed keywords

CORE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVATION; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER FIBROSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; UPREGULATION;

HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; UP-REGULATION; VIRAL CORE PROTEINS; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 0344012537     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10545     Document Type: Article

References (42)

1. Armendariz-Borunda J, Seyer JM, Kang AH, Raghow R. 1990. Regulation of TGF-beta gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 4:215-221.
2. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. 1995. Transforming growth factor-β1 and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21:760-766.
3. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. 1988. Transforming growth factor-beta mRNA increases during liver regeneration. A possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 85:1539-1543.
4. Bursch W, Oberhammer F, Jirtle RL, Askari M, Sedivy R, Grasl-Kraupp B, Purchio AF. 1993. Transforming growth factor-beta1 as a signal for induction of cell death by apoptosis. Br J Cancer 7:531-536.
5. Castilla A, Prieto J, Fausto N. 1991. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon α therapy. N Engl J Med 324:933-940.
6. Chang J, Yang SH, Cho YG, Hwang SB, Hahn YS, Sung YC. 1998. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol 72:3060-3065.
7. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455.
8. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L, Zern MA. 1989. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 108:2477-2482.
9. Fukuda K, Tsuchihara K, Hijikata M, Nishiguchi S, Kuroki T, Shimotohno K. 2001. Hepatitis C virus core protein enhances the activation of the transcription factor, Elkl, in response to mitogenic stimuli. Hepatology 33:159-165.
10. Goto T, Kato N, Suzane Kiyoko ON, Yoshida H, Otsuka M, Shiratori Y, Omata M. 2000. Large isoform of hepatitis delta antigen activates serum response factor-associated transcription. J Biol Chem 275:37311-37316.
11. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385-1395.
12. Gressner AM, Polzar B, Lahme B, Mannherz HG. 1996. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor beta. Hepatology 23:571-581.
13. Hayashi J, Aoki H, Kajino K, Moriyama M, Arakawa Y, Hino O. 2000. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor α. Hepatology 32:958-961.
14. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 88:5547-5551.
15. Kato N, Yoshida H, Ono-Nita SK, Kato J, Goto T, Otsuka M, Lan KH, Matushita K, Shiratori Y, Omata M. 2000. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32:405-412.
16. Kim SJ, Denhez F, Kim KY, Holt JT, Sporn MB, Roberts AB. 1989. Activation of the second promoter of the transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem 264:19373-19378.
17. Kuo G, Choo-QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
18. Marusawa H, Hijikata M, Chiba T, Shimotohno K. 1999. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor α-mediated apoptosis via NF-κB activation. J Virol 73:4713-4720.
19. Massague J, Chen YG. 2000. Controlling TGF-β signaling. Genes Dev 14:627-644.
20. Matsumoto M, Hsieh TY, Zhu N, VanArsdale T, Hwang SB, Jeng KS, Gorbalenya AE, Lo SY, Ou JH, Ware CF, Lai MM. 1997. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor. J Virol 71:1301-1309.
21. Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsuhita M, Sakitani K, Yamashiki N, Seki T, Saito H, Nishizawa M, Fujisawa J, Inoue K. 2000. Autostimulatory mechanism by transforming growth factor β in human hepatocellular carcinoma. Cancer Res 60:1394-1402.
22. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065-1067.
23. Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. 1996. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis. J Gastroenterol Hepatol 11:443-450.
24. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
25. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-betal. Proc Natl Acad Sci USA 89:5408-5412.
26. Otsuka M, Kato N, Lan KH, Yoshida H, Kato J, Goto T, Shiratori Y, Omata M. 2000. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 275:34122-34130.
27. Ray RB, Lagging LM, Meyer K, Steele R, Ray R. 1995. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 37:209-220.
28. Roberts AB, Sporn MB. 1990. The transforming growth factor-βs. In: Roberts AB, Sporn MB, editors. Peptide growth factors and their receptors. Heidelberg, Germany: Springer-Verlag. pp 419-472.
29. Roth S, Michel K, Gressner AM. 1998. (Latent) transforming growth factor in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology 27:1003-1012.
30. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma Proc Natl Acad Sci USA 87:6547-6549.
31. Sambrook J, Russel DW. editors. 2001. Molecular Cloning, 3rd Edition. New York, NY: Cold Spring Harbor Laboratory Press. 1738 p.
32. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. 1995. Hepatic expression of mature transforming growth factor-β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2571-2576.
33. Schmidt C, Royer C, Steffan AM, Labouret N, Caussin C, Navas MC, Jaeck D, Kirn A, Stollkeller F. 1999. Interaction between human hepatic stellate cells and hepatitis C virus. Cells Hepatic Sinusoid 7:249-250.
34. Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, Takaishi K, Kiso S, Matsuzawa Y. 1994. Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer 73:2275-2279.
35. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M. 1995. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 22:1027-1033.
36. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. 1995. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients. Hepatology 21:650-655.
37. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.
38. Tsuchihara K, Hijikata M, Fukuda K, Kuroki T, Yamamoto N, Shimotohno K. 1999. Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Virology 258:100-107.
39. World Health Organization. 2000. WHO Information (http://www.who. int/inf-fs/en/fact164.html).
40. Yoo YD, Ueda H, Park K, Flanders KC, Lee YI, Jay G, Kim SJ. 1996. Regulation of transforming growth factor-β1 expression by the Hepatitis B virus (HBV) X transactivator. J Clin Invest 97:388-395.
41. Yoshida H, Kato N, Shiratori Y, Otsuka M, Maeda S, Kato J, Omata M. 2001. Hepatitis C virus core protein activates nuclear factor κB-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 276:16399-16405.
42. Yue J, Mulder KM. 2000. Requirement of Ras/MAPK pathway activation by transforming growth factor β for transforming growth factor β1 production in a Smad-dependent pathway. J Biol Chem 275:30765-30773.